Retinal nerve fiber layer thickness analysis in suspected malingerers with optic disc temporal pallor.
OBJECTIVE
To investigate the value of temporal retinal nerve fiber layer (RNFL(temporal)) thickness in the prediction of malingering.


METHODS
This prospective, cross-sectional study was conducted on 33 military conscripts with optic disc temporal pallor (ODTP) and 33 age-and sex-matched healthy controls. Initial visual acuity (VA(i)) and visual acuity after simulation examination techniques (VA(aset)) were assessed. The subjects whose VA(aset) were two or more lines higher than VA(i) were determined as malingerers. Thickness of the peripapillary RNFL was determined with OCT (Stratus OCT, Carl Zeiss Meditec, Inc.). RNFL(temporal) thickness of the subjects were categorized into one of the 1+ to 4+ groups according to 50% confidence interval (CI), 25% CI and 5% CI values which were assessed in the control group. The VAs were converted to LogMAR-VAs for statistical comparisons.


RESULTS
A significant difference was found only in the temporal quadrant of RNFL thickness in subjects with ODTP (P =0.002). Mean LogMAR-VA increased significantly after SETs ( P temporal thickness in diagnosing malingering were 84.6%, 75.0%, 68.8%, 88.2%, respectively. ROC curve showed that RNFL(temporal) thickness of 67.5 microm is a significant cut-off point in determining malingering (P =0.001, area under the curve:0.862). The correlations between LogMAR-VAs and RNFL(temporal) thicknesses were significant; the correlation coefficient for LogMAR-VA(i) was lower than the correlation for LogMAR-VA(aset) (r=-0.447, P =0.009 for LogMAR-VA(i); r=-0.676, P<0.001 for LogMAR-VA(aset)).


CONCLUSIONS
RNFL(temporal) thickness assessment may be a valuable tool in determining malingering in subjects with ODTP objectively.
Civelekler
Mustafa
M
Department of Ophthalmology, Gulhane Military Medical Academy, Ankara, Turkey.
Halili
Ismail
I
Gundogan
Fatih C
FC
Sobaci
Güngör
G
D000328:Adult; D016001:Confidence Intervals; D003430:Cross-Sectional Studies; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D008306:Malingering / Q000175:diagnosis*; D008889:Military Personnel; D009412:Nerve Fibers; D009898:Optic Disk / Q000166:cytology*; D011446:Prospective Studies; D012372:ROC Curve; D012016:Reference Values; D015203:Reproducibility of Results; D012165:Retinal Ganglion Cells / Q000166:cytology*; D041623:Tomography, Optical Coherence; D014792:Visual Acuity; D055815:Young Adult
J Nerv Ment Dis. 1978 Aug;166(8):580-7
681918
Psychol Med. 1983 May;13(2):307-14
6348827
Arch Ophthalmol. 1983 May;101(5):729-35
6847460
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4748-52
17898300
Br J Ophthalmol. 2008 Feb;92(2):186-90
18227200
Surv Ophthalmol. 1984 Jan-Feb;28(4):333-8
6701777
Ophthalmology. 2003 Jan;110(1):190-5
12511365
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2440-3
15980233
Surv Ophthalmol. 1979 Sep-Oct;24(2):89-96
515946
Br J Ophthalmol. 1989 Aug;73(8):651-4
2765446
Br J Ophthalmol. 2008 Aug;92(8):1076-80
18586904
Surv Ophthalmol. 2003 Nov-Dec;48(6):626-30
14609708
Ophthalmology. 2002 Apr;109(4):810-5
11927447
Ann Neurol. 2005 Sep;58(3):383-91
16075460
Eye (Lond). 2003 Nov;17(9):1019-24
14704752
Am J Ophthalmol. 1985 Jul 15;100(1):209-13
4014374
Doc Ophthalmol. 1989 Sep;73(1):1-33
2698334
J Glaucoma. 2008 Mar;17(2):122-7
18344758
Ophthalmology. 2008 Apr;115(4):661-666.e4
17706287
Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2520-7
10509645
Lancet Neurol. 2006 Oct;5(10):853-63
16987732
Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5773-81
18055831
Ophthalmology. 1985 Mar;92(3):427-35
3991130
Am J Ophthalmol. 2004 Jan;137(1):135-7
14700656
Ophthalmology. 2007 Dec;114(12):2332-7
17618689
Ophthalmology. 2006 Feb;113(2):324-32
16406539
J Clin Neuroophthalmol. 1990 Jun;10(2):127-30
2141855
Indian J Ophthalmol. 2004 Dec;52(4):303-9
15693322
Surv Ophthalmol. 1973 Jan-Feb;17(4):241-6
4802377
Ophthalmology. 2007 Jun;114(6):1046-52
17210181